Back
Voya Emerging Markets High Dividend Equity Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
65
IHD
Voya Emerging Markets High Dividend Equity Fund
Last Price:
$6.32
Seasonality Move:
2.37%
Sell
43
CRSP
CRISPR Therapeutics AG
Last Price:
$55.85
Seasonality Move:
14.46%
Buy
65
Voya Emerging Markets High Dividend Equity Fund (IHD)
is a Buy
Is Voya Emerging Markets High Dividend Equity Fund a Buy, Sell or Hold?
-
The current Voya Emerging Markets High Dividend Equity Fund [IHD] share price is $6.32. The Score for IHD is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
IHD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IHD Stock Price Chart
What is Voya Emerging Markets High Dividend Equity Fund's stock price today?
-
The Voya Emerging Markets High Dividend Equity Fund share price today is $6.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IHD is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $55.86The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.
IHD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 60.25 | Buy |
| Chaikin Money Flow: | 12670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.11 - 6.25) | Buy |
| Bollinger Bands (100): | (5.98 - 6.32) | Buy |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 49.16 | Sell |
| Chaikin Money Flow: | 78181 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.94 - 57.06) | Buy |
| Bollinger Bands (100): | (52.44 - 65.4) | Sell |
IHD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.22 | Buy |
| 20-day SMA: | 6.19 | Buy |
| 50-day SMA: | 6.24 | Buy |
| 200-day SMA: | 5.82 | Buy |
| 8-day EMA: | 6.22 | Buy |
| 20-day EMA: | 6.21 | Buy |
| 50-day EMA: | 6.2 | Buy |
| 200-day EMA: | 5.91 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.25 | Sell |
| 20-day SMA: | 55.05 | Buy |
| 50-day SMA: | 58.96 | Sell |
| 200-day SMA: | 51.1 | Buy |
| 8-day EMA: | 55.79 | Buy |
| 20-day EMA: | 55.79 | Buy |
| 50-day EMA: | 56.36 | Sell |
| 200-day EMA: | 37.56 | Buy |
Voya Emerging Markets High Dividend Equity Fund Earnings Growth & IHD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Voya Emerging Markets High Dividend Equity Fund Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||